These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8981483)

  • 21. Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange.
    Kearn CS; Greenberg MJ; DiCamelli R; Kurzawa K; Hillard CJ
    J Neurochem; 1999 Jun; 72(6):2379-87. PubMed ID: 10349847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of the cannabinoid receptor agonist WIN 55,212-2 on pentagastrin-induced gastric acid secretion in the anaesthetized rat.
    Coruzzi G; Adami M; Coppelli G; Frati P; Soldani G
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Dec; 360(6):715-8. PubMed ID: 10619190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists.
    Houston DB; Howlett AC
    Cell Signal; 1998 Oct; 10(9):667-74. PubMed ID: 9794249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
    Gerdeman G; Lovinger DM
    J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
    Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
    Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice.
    Monory K; Tzavara ET; Lexime J; Ledent C; Parmentier M; Borsodi A; Hanoune J
    Biochem Biophys Res Commun; 2002 Mar; 292(1):231-5. PubMed ID: 11890697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity.
    Pan X; Ikeda SR; Lewis DL
    Mol Pharmacol; 1998 Dec; 54(6):1064-72. PubMed ID: 9855635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat.
    Izzo AA; Mascolo N; Capasso R; Germanò MP; De Pasquale R; Capasso F
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):221-3. PubMed ID: 10494894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cannabinoid penetration into mouse brain as determined by ex vivo binding.
    Petitet F; Jeantaud B; Bertrand P; Imperato A
    Eur J Pharmacol; 1999 Jun; 374(3):417-21. PubMed ID: 10422786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid receptor antagonism and inverse agonism in response to SR141716A on cAMP production in human and rat brain.
    Mato S; Pazos A; Valdizán EM
    Eur J Pharmacol; 2002 May; 443(1-3):43-6. PubMed ID: 12044790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F
    J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effects of SR141716A on G-protein activation in rat brain.
    Sim-Selley LJ; Brunk LK; Selley DE
    Eur J Pharmacol; 2001 Mar; 414(2-3):135-43. PubMed ID: 11239913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzophenanthridine alkaloid, piperonyl butoxide and (S)-methoprene action at the cannabinoid-1 receptor (CB1-receptor) pathway of mouse brain: Interference with [(3)H]CP55940 and [(3)H]SR141716A binding and modification of WIN55212-2-dependent inhibition of synaptosomal l-glutamate release.
    Dhopeshwarkar AS; Nicholson RA
    Eur J Pharmacol; 2014 Jan; 723():431-41. PubMed ID: 24211785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
    Shivachar AC
    Biochem Pharmacol; 2007 Jun; 73(12):2004-11. PubMed ID: 17445778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of cannabinoid receptor ligands on electrophysiological properties of myenteric neurones of the guinea-pig ileum.
    López-Redondo F; Lees GM; Pertwee RG
    Br J Pharmacol; 1997 Sep; 122(2):330-4. PubMed ID: 9313943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenteric vasodilation mediated by endothelial anandamide receptors.
    Wagner JA; Varga K; Járai Z; Kunos G
    Hypertension; 1999 Jan; 33(1 Pt 2):429-34. PubMed ID: 9931142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabinoids cause central sympathoexcitation and bradycardia in rabbits.
    Niederhoffer N; Szabo B
    J Pharmacol Exp Ther; 2000 Aug; 294(2):707-13. PubMed ID: 10900251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide.
    Mallet PE; Beninger RJ
    Psychopharmacology (Berl); 1998 Nov; 140(1):11-9. PubMed ID: 9862397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors.
    Gatley SJ; Gifford AN; Volkow ND; Lan R; Makriyannis A
    Eur J Pharmacol; 1996 Jul; 307(3):331-8. PubMed ID: 8836622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rat central ORL-1 receptor uncouples from adenylyl cyclase during membrane preparation.
    Okawa H; Hirst RA; Smart D; McKnight AT; Lambert DG
    Neurosci Lett; 1998 Apr; 246(1):49-52. PubMed ID: 9622205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.